Ivanov V N, Bhoumik A, Krasilnikov M, Raz R, Owen-Schaub L B, Levy D, Horvath C M, Ronai Z
The Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.
Mol Cell. 2001 Mar;7(3):517-28. doi: 10.1016/s1097-2765(01)00199-x.
Decreased Fas expression during tumor progression often results in a loss of Fas-ligand (FasL)-mediated apoptosis. Human and mouse melanoma exhibit an inverse correlation between the degree of Fas cell surface expression, tumorigenicity, and metastatic capacity. The expression of dominant negative Stat3 or c-Jun in melanoma cells efficiently increased Fas expression and sensitized cells to FasL-induced apoptosis. Stat3+/- as well as c-Jun-/- cells exhibited increased Fas cell surface expression and higher sensitivity to FasL-mediated apoptosis. Suppression of Fas expression by Stat3 and c-Jun is uncoupled from Stat3-mediated transcriptional activation. Our findings indicate that Stat3 oncogenic activities could also be mediated through its cooperation with c-Jun, resulting in downregulation of Fas surface expression, which is implicated in the tumor's ability to resist therapy and metastasize.
肿瘤进展过程中Fas表达降低通常会导致Fas配体(FasL)介导的细胞凋亡丧失。人和小鼠黑色素瘤在Fas细胞表面表达程度、致瘤性和转移能力之间呈现负相关。黑色素瘤细胞中显性负性Stat3或c-Jun的表达有效增加了Fas表达,并使细胞对FasL诱导的凋亡敏感。Stat3+/-以及c-Jun-/-细胞表现出Fas细胞表面表达增加以及对FasL介导的凋亡更高的敏感性。Stat3和c-Jun对Fas表达的抑制与Stat3介导的转录激活无关。我们的研究结果表明,Stat3致癌活性也可能通过其与c-Jun的合作介导,导致Fas表面表达下调,这与肿瘤抵抗治疗和转移的能力有关。